Hospital frailty risk and CHA2DS2-VA scores in the mortality assessment of older patients with peripheral artery disease.

IF 2.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Vasa-european Journal of Vascular Medicine Pub Date : 2025-05-01 Epub Date: 2025-02-17 DOI:10.1024/0301-1526/a001183
Sven M Piepenburg, Mariya Maslarska, Christian Weber, Klaus Kaier, Constantin von Zur Mühlen, Dirk Westermann, Christoph Hehrlein
{"title":"Hospital frailty risk and CHA2DS2-VA scores in the mortality assessment of older patients with peripheral artery disease.","authors":"Sven M Piepenburg, Mariya Maslarska, Christian Weber, Klaus Kaier, Constantin von Zur Mühlen, Dirk Westermann, Christoph Hehrlein","doi":"10.1024/0301-1526/a001183","DOIUrl":null,"url":null,"abstract":"<p><p><b></b> <i>Background:</i> Older patients with peripheral artery disease (PAD) encounter an increased risk of in-hospital mortality. Accurate risk scoring methods are crucial for assessing the likelihood of cardiovascular events in these patients. However, a comprehensive comparison of these scoring methods for predicting in-hospital mortality in PAD patients has not yet been conducted. <i>Patients and methods:</i> This study analyzed 173,075 patients hospitalized with PAD in the year 2020 from a German nationwide registry. We assessed five risk scores: the Elixhauser Comorbidity Index, the Charlson Comorbidity Index, the CHA<sub>2</sub>DS<sub>2</sub>-VA Score, the EuroSCORE, and the Hospital Frailty Risk Score (HFRS). The average patient age was 72 ± 10.94 years, with 36.82% female and 35.27% also diagnosed with diabetes mellitus. The overall in-hospital mortality rate was 2.68%. Mean scores were 7.12±6.55 for the Elixhauser Comorbidity Index, 2.66±1.72 for the Charlson Comorbidity Index, 3.85±1.43 for the CHA<sub>2</sub>DS<sub>2</sub>-VA Score, 8.96%±8.85% for the EuroSCORE, and 3.53±5 for the HFRS. The HFRS showed the highest predictive potential for in-hospital mortality with an area under the curve (AUC) of 0.86 (95% confidence interval (CI): 0.86-0.87) but had the worst calibration for high-risk patients. The CHA<sub>2</sub>DS<sub>2</sub>-VA Score had the lowest AUC 0.69 (95% CI: 0.68-0.70) but was the most consistent prediction model regarding calibration. <i>Conclusions:</i> HFRS was the most effective overall predictor of in-hospital mortality, but did not detect those patients with a very high risk of mortality. The CHA<sub>2</sub>DS<sub>2</sub>-VA Score was the most robust predictor of increasing score points but had the lowest sensitivity. Therefore, use of the HFRS combined with application of the CHA<sub>2</sub>DS<sub>2</sub>-VA Score appears to be most appropriate in identifying older PAD patients at risk of in-hospital mortality.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":"201-208"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vasa-european Journal of Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1024/0301-1526/a001183","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Older patients with peripheral artery disease (PAD) encounter an increased risk of in-hospital mortality. Accurate risk scoring methods are crucial for assessing the likelihood of cardiovascular events in these patients. However, a comprehensive comparison of these scoring methods for predicting in-hospital mortality in PAD patients has not yet been conducted. Patients and methods: This study analyzed 173,075 patients hospitalized with PAD in the year 2020 from a German nationwide registry. We assessed five risk scores: the Elixhauser Comorbidity Index, the Charlson Comorbidity Index, the CHA2DS2-VA Score, the EuroSCORE, and the Hospital Frailty Risk Score (HFRS). The average patient age was 72 ± 10.94 years, with 36.82% female and 35.27% also diagnosed with diabetes mellitus. The overall in-hospital mortality rate was 2.68%. Mean scores were 7.12±6.55 for the Elixhauser Comorbidity Index, 2.66±1.72 for the Charlson Comorbidity Index, 3.85±1.43 for the CHA2DS2-VA Score, 8.96%±8.85% for the EuroSCORE, and 3.53±5 for the HFRS. The HFRS showed the highest predictive potential for in-hospital mortality with an area under the curve (AUC) of 0.86 (95% confidence interval (CI): 0.86-0.87) but had the worst calibration for high-risk patients. The CHA2DS2-VA Score had the lowest AUC 0.69 (95% CI: 0.68-0.70) but was the most consistent prediction model regarding calibration. Conclusions: HFRS was the most effective overall predictor of in-hospital mortality, but did not detect those patients with a very high risk of mortality. The CHA2DS2-VA Score was the most robust predictor of increasing score points but had the lowest sensitivity. Therefore, use of the HFRS combined with application of the CHA2DS2-VA Score appears to be most appropriate in identifying older PAD patients at risk of in-hospital mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医院衰弱风险和CHA2DS2-VA评分在老年外周动脉疾病患者死亡率评估中的应用
背景:患有外周动脉疾病(PAD)的老年患者在医院死亡的风险增加。准确的风险评分方法对于评估这些患者发生心血管事件的可能性至关重要。然而,目前还没有对这些预测PAD患者住院死亡率的评分方法进行全面比较。患者和方法:本研究分析了2020年德国全国登记的173075名PAD住院患者。我们评估了五种风险评分:Elixhauser共病指数、Charlson共病指数、CHA2DS2-VA评分、EuroSCORE和医院虚弱风险评分(HFRS)。患者平均年龄为72±10.94岁,女性占36.82%,合并糖尿病占35.27%。住院总死亡率为2.68%。Elixhauser合并症指数为7.12±6.55分,Charlson合并症指数为2.66±1.72分,CHA2DS2-VA评分为3.85±1.43分,EuroSCORE为8.96%±8.85%,HFRS为3.53±5分。HFRS对住院死亡率的预测潜力最高,曲线下面积(AUC)为0.86(95%可信区间(CI): 0.86-0.87),但对高危患者的校准效果最差。CHA2DS2-VA评分具有最低的AUC 0.69 (95% CI: 0.68-0.70),但在校准方面是最一致的预测模型。结论:HFRS是院内死亡率最有效的总体预测指标,但不能检测出死亡率非常高的患者。CHA2DS2-VA评分是评分增加最可靠的预测因子,但敏感度最低。因此,将HFRS与CHA2DS2-VA评分结合使用似乎最适合用于识别有院内死亡风险的老年PAD患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.90
自引率
11.10%
发文量
61
审稿时长
1 months
期刊介绍: Vasa is the European journal of vascular medicine. It is the official organ of the German, Swiss, and Slovenian Societies of Angiology. The journal publishes original research articles, case reports and reviews on vascular biology, epidemiology, prevention, diagnosis, medical treatment and interventions for diseases of the arterial circulation, in the field of phlebology and lymphology including the microcirculation, except the cardiac circulation. Vasa combines basic science with clinical medicine making it relevant to all physicians interested in the whole vascular field.
期刊最新文献
Endovascular treatment of severely calcified aortoiliac occlusive disease: long-term outcomes from a single-centre cohort. Interdepartmental cooperation in access-site management - verifiable persistent benefit for patients. Correction to H. Jalaie et al. (2021). The effects of adding physiotherapy to compression therapy on function and oedema in chronic venous insufficiency. Radiofrequency vs mechanochemical ablation for small saphenous vein insufficiency.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1